Parker Institute for Cancer Immunotherapy

Analysis

Parker Institute for Cancer Immunotherapy is a registered charity in United States, based in San Francisco, CA. It received its IRS tax-exemption ruling in June 2015, 11 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Parker Institute for Cancer Immunotherapy reported income of $23.7m and spending of $42.9m, spending 181% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $162.6m to $23.7m (-85%), an average of -38% a year. The sharpest change came in the year to December 2021, when income rose by 159%. Over the whole period it spent 67% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Parker Institute for Cancer Immunotherapy sits at the 90th percentile: it is larger than about 90% of them. Against every charity in United States with reported income it ranks in the 97th percentile, and in the 98th percentile within CA. Charities of a similar size with the same main cause include El Dorado County Community Health ($23.7m), Caromont Health Inc ($23.7m) and Napoleon Care Center ($23.7m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 5.1% and program service revenue 37% of the total. Compensation of current officers, directors and key employees was $2.2m (5.2% of expenses). Other salaries and wages came to $7.6m. At year end it held assets of $255.0m against liabilities of $52.8m, net assets of $202.2m. It reported 49 employees.